HealthFollow this section to personalize your feed and get instant alerts.FollowGo to your personalized feedWHY FOLLOW?Update your preferences in Account SettingsCancerFollow this tag to personalize your feed and get instant alerts.ADD TIME ON GOOGLEby Alice ParkOpen follow modalPersonalized ContentAlice ParkFollow this author to personalize your feed and get instant alerts.by Alice ParkOpen follow modalPersonalized ContentModerna and Merck reported on Oct.
22 that a customized cancer vaccine for people with late-stage melanoma can reduce the risk of cancer recurrence or death over two years by 42% compared to current treatment.The results will be presented at the European Society of Medical Oncology meeting in Madrid on Oct.
24.The study involved more than 1,130 people with Stage 2B to St…
المصدر: time
